Startup | November 21, 2025
Teva launches 'Teva Rise' to harness global innovation and transform healthcare
The initiative aims to connect startups and tech companies with its business units,
The initiative aims to connect startups and tech companies with its business units,
Merus has licensed Halozyme’s proprietary ENHANZE technology to develop and commercialize subcutaneous formulations of petosemtamab
ALBIS will present a selection of advanced materials from its broad healthcare portfolio
The FDA is initiating removal of the boxed warnings following a comprehensive review of the scientific literature
Fenebrutinib targets cells in the immune system known as B cells and microglia
The expanded mbDNA portfolio delivers enhanced stability, reduced immunogenicity, and broad compatibility with gene insertion and expression technologies
Relmada expects to initiate its Phase 3 program in the first half of 2026
Bayer remains a key partner in Ginkgo Bioworks’ growing agricultural biologicals platform
From material selection to cooling tower management, every small decision affects long-term equipment reliability
Upon completion, Kimberly-Clark shareholders are expected to own about 54% of the combined entity, while Kenvue shareholders will hold the remaining 46%
Subscribe To Our Newsletter & Stay Updated
